IP Library Granted Patent US 10,598,652
Granted Patent B2
US 10,598,652 · App. 15/564,820 · Granted Mar 24, 2020

Methods of diagnosing post-operative complications using serum nitric oxide levels

Inventors: Hua Cai (Los Angeles, CA); Kimberly Howard-Quijano (Los Angeles, CA); Aman Mahajan (Sherman Oaks, CA); Ji Youn Youn (Los Angeles, CA)
Assignee: The Regents of the University of California
G01N33/4925A61B5/145C01B21/24A61B5/7275G01N2800/326G01N2800/50G01N2800/7009
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,598,652
App. No.
15/564,820
Granted
Mar 24, 2020
Kind
B2
Abstract

Disclosed herein are methods of using serum nitric oxide levels to diagnose subjects as having or likely to develop a post-operative complication.

Claims (16)

1. A method of treating a subject after having had an operation, which comprises administering to the subject a pharmacologic agent known to treat atrial fibrillation and/or subjecting the subject to atrial pacing protocols where, at 24 hours postop, the subject exhibits a negative change in serum nitrogen oxide concentration that is at least about 28% more than the average percent decrease exhibited by normal control subjects.

2. The method according to claim 1 , which further comprises optimizing the fluid status and correcting fluid volume deficits in the subject to maintain a mean blood pressure of greater than 65 mmHg and central venous pressure of greater than 8-12 mmHg in the subject and/or reducing dosages of nephrotoxic medications administered to the subject where, at 24 hours postop, the subject exhibits a negative change in serum nitrogen oxide concentration that is about 64-67% more than the average percent decrease exhibited by normal control subjects.

3. The method according to claim 1 , wherein the percent decrease is about 28-58% more than the average percent decrease exhibited by normal control subjects.

4. The method according to claim 1 , wherein the subject is treated before atrial fibrillation occurs.

5. The method according to claim 2 , wherein the subject is treated before acute kidney injury occurs.

6. The method according to claim 1 , wherein the operation is cardiac surgery.

7. The method according to claim 1 , wherein the operation is cardiac surgery with cardiopulmonary bypass.

8. A method of treating a subject after having had an operation, which comprises administering to the subject a pharmacologic agent known to treat atrial fibrillation and/or subjecting the subject to atrial pacing protocols where, at 24 hours postop, the subject exhibits at least about a 40% decrease in serum nitric oxide concentration.

9. The method according to claim 8 , wherein the percent decrease is about 28-58% more than the average percent decrease exhibited by normal control subjects.

10. The method according to claim 8 , wherein the subject is treated before atrial fibrillation occurs.

11. The method according to claim 8 , wherein the operation is cardiac surgery.

12. The method according to claim 8 , wherein the operation is cardiac surgery with cardiopulmonary bypass.

13. A method of treating a subject after having had an operation, which comprises optimizing the fluid status and correcting fluid volume deficits in the subject to maintain a mean blood pressure of greater than 65 mmHg and central venous pressure of greater than 8-12 mmHg in the subject and/or reducing dosages of nephrotoxic medications administered to the subject where, at 24 hours postop, the subject exhibits (a) a negative change in serum nitrogen oxide concentration that is about 64-67% more than the average percent decrease exhibited by normal control subjects, or (b) about a 55-60% decrease in serum nitric oxide concentration.

14. The method according to claim 13 , wherein the subject is treated before acute kidney injury occurs.

15. The method according to claim 13 , wherein the operation is cardiac surgery.

16. The method according to claim 13 , wherein the operation is cardiac surgery with cardiopulmonary bypass.

Assignments (1)
CONFIRMATORY LICENSE Recorded Oct 19, 2017
From: UNIVERSITY OF CALIFORNIA LOS ANGELES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044229/0646 →
Continuity (2)
Provisional Application 62145449 · Apr 9, 2015
Related Publication 20180113112A1 · Apr 26, 2018